Retrotope
Pioneering a novel drug platform to safeguard and rejuvenate mitochondrial health in degenerative diseases.
General Information
BounceWatch is an independent company data service, not affiliated with Retrotope. To contact Retrotope, visit retrotope.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Retrotope compare?
A PDF of Retrotope and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Retrotope soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Retrotope
Business keywords: biomedical research, neurological diseases, mitochondrial health, drug development, degenerative diseases, oxidative stress, isotope effect, pharmaceuticals, biopolymers, metabolic processes, Friedreich's ataxia, California, innovation, startup
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series D | $50.00M | - |
|
18 Sep 2020 |
| Series C | $20.00M | 3 |
MEHTA FAMILY PARTNERS, Timur Artemev +1
|
30 Nov 2018 |
| Debt Financing | $2.73M | - |
|
14 Nov 2016 |
| Series B | $10.00M | 5 |
|
15 Jan 2015 |
Retrotope Alternatives & Competitors
View All Alternatives
Dedicated to delivering and supporting innovative research-based wellness solutions for whole body h...
Innovative biotechnological advancements for targeting metabolic pathways in cancer cells.
Patented Mitochondrial Support Backed by 20 Years of Research.
FAQ About Retrotope
Source: BounceWatch company record for Retrotope, https://bouncewatch.com/company/retrotope, updated 26 December 2024. When citing, please name BounceWatch and link this page.
